Skip to main content

Table 1 Demographic of participants (N = 108)

From: Variations in the sleep-related breathing disorder index on polysomnography between men with HIV and controls: a matched case-control study

Variables

Overall

Controls

(n = 54)

HIV

(n = 54)

p

n (%)

Age (years)[ Mean, SD]

33.75, 8.94

32.59, 8.91

34.90, 8.90

0.182

AHI (event/hour)

   

1.000

 <5

40 (37.0)

20 (37.0)

20 (37.0)

 

 5–15

36 (33.3)

18 (33.3)

18 (33.3)

 

 15–30

16 (14.8)

8 (14.8)

8 (14.8)

 

 >30

16 (14.8)

8 (14.8)

8 (14.8)

 

 Mean, SD

16.49, 21.16

18.72, 25.59

14.27, 15.45

0.276

BMI kg/m2 (Mean, SD)

25.48, 5.84

27.22, 6.93

23.74, 3.84

0.002

Neck size (cm) [Mean, SD]

37.52, 3.33

38.58, 3.81

36.45, 2.33

0.001

Education level

   

0.164

 Under Senior

23 (22.1)

9 (16.7)

14 (28.0)

 

 University and above

81 (77.9)

45 (83.3)

36 (72.0)

 

Work status

   

0.097

 No

5 (4.7)

1 (1.9)

4 (7.4)

 

 Part-time

72 (67.9)

35 (67.3)

37 (68.5)

 

 Full-time

8 (7.5)

3 (5.8)

5 (9.3)

 

 Others

21 (19.8)

15 (25.0)

8 (14.9)

 

Comorbidities

    

 Hypertension

11 (10.6)

7 (14.0)

4 (7.4)

0.275

 Diabetes Mellitus

1 (0.9)

1 (1.9)

0 (0.0)

0.306

 Hyperlipidemia

15 (14.2)

8 (15.4)

7 (13.0)

0.721

 Hyperuricemia

10 (9.4)

7 (13.5)

3 (5.6)

0.164

Time since HIV diagnosis (year)

3.53, 3.90

na

3.53, 3.90

na

HAART use

50 (92.6)

na

50 (92.6)

na

Years from HAART initiation

2.38, 3.40

na

2.38, 3.40

na

Viral load undetectable

41 (75.9)

na

41 (75.9)

na

CD4 value at time of examination (mean, SD)

560.53, 245.40

na

560.53, 245.40

na

  1. Note apnea hypopnea index, AHI; body mass index, BMI; highly active antiretroviral therapy, HAART, non-available, na
  2. Bold font indicates statistical significance